Daiken Medical Co., Ltd. (7775.T)
JPY 513.0
(-0.58%)
JPY 513.0
(-0.58%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.55 Billion | 989.15 Million | 1.13 Billion | 609.17 Million | 1.43 Billion | 880.92 Million |
| Net Income | 988.6 Million | 1.02 Billion | 1.15 Billion | 944.75 Million | 1.19 Billion | 1.15 Billion |
| Depreciation & Amortization | 216.14 Million | 267.29 Million | 314.42 Million | 256.51 Million | 253.17 Million | 302.87 Million |
| Deferred income taxes | - | -354.62 Million | -221.45 Million | - | - | - |
| Stock-based compensation | 11.29 Million | 13.52 Million | 7.36 Million | - | - | - |
| Change in working capital | 318.64 Million | 2.16 Million | -147.29 Million | -248.84 Million | 288.73 Million | -331.72 Million |
| Other non-cash items | 389.16 Million | 35.77 Million | 29.23 Million | -343.25 Million | -296.11 Million | -243.89 Million |
| Investing Cash Flow | -168.76 Million | -210.52 Million | -196.23 Million | -311.9 Million | -160.76 Million | -208.79 Million |
| Investments in PPE | -168.8 Million | -199.04 Million | -203.21 Million | -312.04 Million | -169.16 Million | -207.16 Million |
| Acquisitions | - | - | 912 Thousand | -4.09 Million | - | - |
| Investment purchases | - | - | - | -733 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | 874 Thousand | 44.46 Million | - |
| Other Investing Activities | 35.99 Thousand | -11.47 Million | 6.06 Million | 4.09 Million | -36.06 Million | -1.63 Million |
| Financing Cash Flow | -1.16 Billion | -781 Million | -589.43 Million | -492.02 Million | -1.12 Billion | -822.73 Million |
| Debt repayment | -589.84 Million | -604.49 Million | -704.03 Million | -908.03 Million | -873.99 Million | -645.66 Million |
| Dividends payments | -573.95 Million | -565.32 Million | -574.29 Million | -574.88 Million | -546.12 Million | -773.33 Million |
| Common Stock Repurchased | -1000.00 | - | - | - | - | -999.99 Million |
| Common Stock Issuance | - | - | - | - | - | 1.59 Billion |
| Other Financing Activities | -1000.00 | 388.8 Million | 688.89 Million | 990.89 Million | 291.77 Million | -1000.00 |
| Accounts receivables | 48.99 Million | -99 Million | 156 Million | 138 Million | -132 Million | 155 Million |
| Accounts payables | -50.4 Million | 113.3 Million | 46.18 Million | -8.74 Million | 129.65 Million | -92.69 Million |
| Inventory | 76.64 Million | 29.83 Million | -122.62 Million | -248.45 Million | 326.41 Million | -269.7 Million |
| Other working capital | 243.4 Million | -41.98 Million | -226.84 Million | -129.64 Million | -35.33 Million | -124.33 Million |
| Cash at beginning of period | 2.51 Billion | 2.51 Billion | 2.17 Billion | 2.36 Billion | 2.21 Billion | 2.36 Billion |
| Cash at end of period | 2.73 Billion | 2.51 Billion | 2.51 Billion | 2.17 Billion | 2.36 Billion | 2.21 Billion |
| Capital Expenditure | -168.8 Million | -199.04 Million | -203.21 Million | -312.04 Million | -169.16 Million | -207.16 Million |
| Effect of forex changes on cash | - | - | -1000.00 | - | - | - |
| Net cash flow / Change in cash | 222.92 Million | -2.37 Million | 347.94 Million | -194.75 Million | 147.79 Million | -150.6 Million |
| Free Cash Flow | 1.38 Billion | 790.1 Million | 930.4 Million | 297.12 Million | 1.26 Billion | 673.76 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 289 Million | 100 Million | 988.6 Million | 351 Million | 293 Million | 244 Million |
| Depreciation & Amortization | - | - | 216.14 Million | 53.73 Million | 52.3 Million | 51.88 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 11.29 Million | - | - | - |
| Change in working capital | - | - | 318.64 Million | - | - | - |
| Other non-cash items | -289 Million | -100 Million | 389.16 Million | -351 Million | -293 Million | -244 Million |
| Investing Cash Flow | - | - | -168.76 Million | - | - | - |
| Investments in PPE | - | - | -168.8 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 35.99 Thousand | - | - | - |
| Financing Cash Flow | - | - | -1.16 Billion | - | - | - |
| Debt repayment | - | - | -589.84 Million | - | - | - |
| Dividends payments | - | - | -573.95 Million | - | - | - |
| Common Stock Repurchased | - | - | -1000.00 | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -1000.00 | - | - | - |
| Accounts receivables | - | - | 48.99 Million | - | - | - |
| Accounts payables | - | - | -50.4 Million | - | - | - |
| Inventory | - | - | 76.64 Million | - | - | - |
| Other working capital | - | - | 243.4 Million | - | - | - |
| Cash at beginning of period | - | - | 2.51 Billion | 2.65 Billion | 2.48 Billion | 2.51 Billion |
| Cash at end of period | - | - | 2.73 Billion | 2.51 Billion | 2.65 Billion | 2.48 Billion |
| Capital Expenditure | - | - | -168.8 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 222.92 Million | -141.04 Million | 168.67 Million | -27.37 Million |
| Free Cash Flow | - | - | 1.38 Billion | 107.46 Million | 104.6 Million | 103.76 Million |
8229
1690
TRZ
GFTU
026890
AKI